 WILMINGTON, Del., Jan. 04, 2022 GLOBE NEWSWIRE -- Prelude Therapeutics Inc. Nasdaq: PRLD, a clinical-stage precision oncology company, today announced that Kris Vaddi, PhD, Chief Executive Officer, will present at the H.C Wainwright BioConnect Virtual Conference, being held on January 10-13, 2022. 